News Tagged ‘severe sepsis’

FDA issues notice to health care providers about sepsis drug

The FDA recently issued a notice to critical health care professionals warning of the risk of serious bleeding events and mortality in patients who received Xigris, a medication approved by the FDA for the treatment of adult high-risk severe sepsis. Sepsis is a common, deadly and underdiagnosed disease that can develop as a complication after illnesses such as pneumonia and bacterial infections. High-risk sepsis is sepsis associated with acute organ dysfunction. Xigris is indicated when cardiovascular, renal or respiratory dysfunction occurs with severe sepsis.

Read the rest of this entry »